Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 31, 2023 07:00 ET | Source: Travere Therapeutics, Inc.

Travere Therapeutics Announces Positive Topline Results from Cohort 6 in the Phase 1/2 COMPOSE Study of Pegtibatinase in Classical Homocystinuria

Data from the four patients treated with the highest dose of pegtibatinase showed a clinically meaningful 67.1% mean relative reduction in total homocysteine from baseline Pegtibatinase has...
July 29, 2015 18:20 ET | Source: JayMac Pharmaceuticals

EnLyte Monotherapy Reduces Toxic Homocysteine in Patients With MTHFR Polymorphism: Breakthrough Study Shows Significant Reduction In Toxic Amino Acid Linked To Hundreds Of Diseases

SUNSET, La., July 29, 2015 (GLOBE NEWSWIRE) -- A new study shows patients with the MTHFR C677T/A1298C enzyme polymorphism significantly benefit from reduced B vitamin therapy, marketed under the...
July 29, 2015 18:03 ET | Source: JayMac Pharmaceuticals

New Study Shows Homocysteine Reduction Directly Correlates With Higher Remission Rates in Depression

SUNSET, La., July 29, 2015 (GLOBE NEWSWIRE) -- It has been common knowledge in the medical community that administering B9 (folates), B12, and B6 will lower homocysteine levels in the body. However,...
July 29, 2015 18:02 ET | Source: JayMac Pharmaceuticals (EnLyte)

New Study Proves Homocysteine Theory of Depression: Lower Homocysteine, Achieve Higher Remission Rates in Major Depressive Disorder

SUNSET, La., July 29, 2015 (GLOBE NEWSWIRE) -- Major Depressive Disorder (MDD) affects up to 25% of people and the literature is clear that previous standards of treatment fall short: only 30% of...